Our cross-age analysis of #KMT2A rearranged #B-ALL is out in @hemasphere-journal.bsky.social: advancing age 👶👵 is linked to immaturity🌱, chemotherapy resistance and poor outcome with RNA-seq providing a lense into these connections. 👏 to Alina Hartmann and our team! 📎 doi.org/10.1002/hem3...

L’ #immunothérapie à double #CAR_T 🧬 en vente éradique la #Leucémie 🩸 à haut risque médullaire et leptoméningée à haut risque de #KMT2A
ashpublications.org/blood/articl...

Synapse: Your Connection to our MSK Authors
Meet: Juan Yan
Research Focus: Human Oncology and Pathogenesis Program; Senior Research Scientist

synapse.mskcc.org/synapse/work...

#KMT2C #KMT2D #KMT2A #Epigenetics #UrothelialCancer #BladderCancer #Tumorigenesis #ChromatinBiology #GeneRegulation